4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001871423-26-000002
Options or other derivatives
- Chief Financial Officer acquired 140,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Maestas Nicholas Chief Financial Officer | 2026-03-31 | Grant or award · Employee Stock Option (right to buy) | +140,000 | 140,000 | D | ||
Loading xslF345X06/form4-04022026_050421.xml…